Oddo BHF Asset Management Sas’ holdings in AbbVie were worth $12,878,000 as of its most recent SEC filing. Eclectic Associates Inc. ADV grew its stake in shares of AbbVie by 0.8% during the fourth quarter. Dogwood Wealth Management LLC increased its holdings in shares of AbbVie by 10.8% during the fourth quarter. Positive Sentiment: RINVOQ also received EU approval for non-segmental vitiligo in patients 12 and older who are candidates for systemic therapy. AbbVie Company Profile(Free Report)AbbVie is a global, research-driven biopharmaceutical company that was created as a spin-off from Abbott Laboratories in 2013 and is headquartered in North Chicago, Illinois.